BAIRD MEDICAL INVESTMENT HOLDINGS LIMITED

NASDAQ: BDMD (Baird Medical Investment Holdin)

Last update: 07 Apr, 7:05PM

5.62

-0.33 (-5.55%)

Previous Close 5.95
Open 5.58
Volume 14,663
Avg. Volume (3M) 481,218
Market Cap 204,355,552
Price / Earnings (TTM) 16.06
Price / Sales 5.96
Price / Book 5.14
52 Weeks Range
1.05 (-81%) — 13.52 (140%)
Profit Margin 37.96%
Operating Margin (TTM) 38.74%
Diluted EPS (TTM) 0.350
Quarterly Revenue Growth (YOY) 13.80%
Quarterly Earnings Growth (YOY) 85.80%
Total Debt/Equity (MRQ) 39.53%
Current Ratio (MRQ) 2.10
Operating Cash Flow (TTM) -5.62 M

Market Trend

Short Term Medium Term
Industry Medical Devices (US) Mixed Mixed
Medical Devices (Global) Mixed Mixed
Stock Baird Medical Investment Holdin - -

AIStockmoo Score

-0.4
Analyst Consensus 0.0
Insider Activity NA
Price Volatility -2.0
Technical Moving Averages 0.0
Technical Oscillators 0.5
Average -0.38

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
BDMD 204 M - 16.06 5.14
BBNX 570 M - - -
CBLL 538 M - - 2.83
MGRM 88 M - - 6.57
DHAI 59 M - - 3.03
MDAI 33 M - - -

Baird Medical Investment Holdings Ltd is one of the microwave ablation medical device developers and providers in the PRC for minimally invasive treatment of tumors. Its proprietary medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps. Microwave ablation is a minimally invasive treatment technique that denaturalizes and coagulates the protein of tumor cells with extreme heat generated by microwave energy. Microwave ablation treatments have been applied to benign and malignant tumors, and the company believes the products are safer, minimally invasive and easier to operate with faster recovery periods and lower complication rates for patients, as compared to traditional treatment methods.

Sector Healthcare
Industry Medical Devices
% Held by Insiders 22.16%
% Held by Institutions 1.56%

No data within this time range.

No data within this time range.

Date Type Details
06 May 2025 Announcement Baird Medical to Participate in the AAES 2025 Annual Meeting
05 May 2025 Announcement Baird Medical to Participate in COSM 2025 Conference
28 Apr 2025 Announcement Baird Medical Hosts Advanced Microwave Ablation Training with Top Thyroid Specialists
24 Apr 2025 Announcement Baird Medical Hosts Malaysian Thyroid Specialists for Advanced Microwave Ablation Training in China
14 Apr 2025 Announcement Baird Medical Presents Advanced MWA Technology to UCLA Expert in China
09 Apr 2025 Announcement Baird Medical Advances Global Expansion of Microwave Ablation Technology
02 Apr 2025 Announcement Baird Medical Showcases Advanced MWA Technology with UCSF Expert in Guangzhou and Shenzhen
31 Mar 2025 Announcement Baird Medical's MWA Technology Successfully Applied in Endocrine Procedures
24 Mar 2025 Announcement Baird Medical Wins "Most Valuable Investment Award" for AI Tumor Ablation Surgical Robot
17 Mar 2025 Announcement Baird Medical's AI Tumor Ablation Surgical Robot Wins "Most Valuable Investment Award," Pioneering AI and Robotics Integration in Healthcare
10 Mar 2025 Announcement Baird Medical Secures Indonesian Regulatory Approval for Microwave Ablation Technology
03 Mar 2025 Announcement Baird Medical Showcases Cutting-Edge MWA Innovations at NASOIE 2025
26 Feb 2025 Announcement Baird Medical Expands Global MWA Training with Expert-Led Program in Guangzhou
10 Feb 2025 Announcement Baird Medical Advances MWA Training with Expert-Led Course at Columbia Thyroid Center
Show more

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria